Literature DB >> 24481566

Neuroprotection by the synthetic neurosteroid enantiomers ent-PREGS and ent-DHEAS against Aβ₂₅₋₃₅ peptide-induced toxicity in vitro and in vivo in mice.

Fadia El Bitar1,2, Johann Meunier3, Vanessa Villard3, Marion Alméras3, Kathiresan Krishnan4, Douglas F Covey4, Tangui Maurice3, Yvette Akwa1.   

Abstract

RATIONALE: Pregnenolone sulfate (PREGS) and dehydroepiandrosterone sulphate (DHEAS) are pro-amnesic, anti-amnesic and neuroprotective steroids in rodents. In Alzheimer's disease (AD) patient's brains, their low concentrations are correlated with high levels of Aβ and tau proteins. The unnatural enantiomer ent-PREGS enhanced memory in rodents. We investigated here whether ent-PREGS and ent-DHEAS could be neuroprotective in AD models.
OBJECTIVE: The effects of PREGS, ent-PREGS, DHEAS and ent-DHEAS against Aβ25-35 peptide-induced toxicity were examined in vitro on B104 neuroblastoma cells and in vivo in mice.
METHODS: B104 cells pretreated with the steroids before Aβ25-35 were analysed by flow cytometry measuring cell viability and death processes. Mice injected intracerebroventricularly with Aβ25-35 and the steroids were analysed for their memory abilities. Additionally, lipid peroxidation levels in the hippocampus were measured.
RESULTS: ent-PREGS and PREGS significantly attenuated the Aβ25-35-induced decrease in cell viability. Both steroids prevented the Aβ25-35-induced increase in late apoptotic cells. PREGS further attenuated the ratio of necrotic cells. ent-DHEAS and DHEAS significantly reduced the Aβ25-35-induced toxicity and prevented the cells from entering late apoptosis and necrosis. All steroids stimulated neurite outgrowth per se and prevented the Aβ25-35-induced decrease. In vivo, ent-PREGS and ent-DHEAS significantly attenuated the Aβ25-35-induced decrease in memory (spontaneous alternation and passive avoidance) and an increase in lipid peroxidation levels. In contrast to the natural steroids, both enantiomers prevented amnesia when injected 6 h before Aβ25-35 in contrast to the natural steroids.
CONCLUSION: The unnatural steroids ent-PREGS and ent-DHEAS are potent neuroprotective agents and could be effective therapeutical tools in AD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24481566      PMCID: PMC4188413          DOI: 10.1007/s00213-014-3435-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  59 in total

1.  DHEAS improves learning and memory in aged SAMP8 mice but not in diabetic mice.

Authors:  Susan A Farr; William A Banks; Kayoko Uezu; F Spencer Gaskin; John E Morley
Journal:  Life Sci       Date:  2004-10-22       Impact factor: 5.037

2.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

3.  Dehydroepiandrosterone and its sulfate enhance memory retention in mice.

Authors:  J F Flood; G E Smith; E Roberts
Journal:  Brain Res       Date:  1988-05-03       Impact factor: 3.252

4.  Protein complexity of central nervous system cell lines.

Authors:  D Schubert; B Brass; J P Dumas
Journal:  J Neurosci       Date:  1986-10       Impact factor: 6.167

5.  Clonal cell lines from the rat central nervous system.

Authors:  D Schubert; S Heinemann; W Carlisle; H Tarikas; B Kimes; J Patrick; J H Steinbach; W Culp; B L Brandt
Journal:  Nature       Date:  1974-05-17       Impact factor: 49.962

6.  Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats.

Authors:  M Yu Stepanichev; Yu V Moiseeva; N A Lazareva; M V Onufriev; N V Gulyaeva
Journal:  Brain Res Bull       Date:  2003-07-15       Impact factor: 4.077

Review 7.  Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists.

Authors:  D Allan Butterfield; Sue Griffin; Gerald Munch; Giulio Maria Pasinetti
Journal:  J Alzheimers Dis       Date:  2002-06       Impact factor: 4.472

8.  Effect of beta amyloid peptides on neurons in hippocampal slice cultures.

Authors:  A T Malouf
Journal:  Neurobiol Aging       Date:  1992 Sep-Oct       Impact factor: 4.673

9.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.

Authors:  M P Mattson; B Cheng; D Davis; K Bryant; I Lieberburg; R E Rydel
Journal:  J Neurosci       Date:  1992-02       Impact factor: 6.167

Review 10.  Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.

Authors:  D Allan Butterfield; Alessandra Castegna; Christopher M Lauderback; Jennifer Drake
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

View more
  5 in total

1.  Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABAA receptors.

Authors:  Manasa L Parakala; Yihui Zhang; Amit Modgil; Jayashree Chadchankar; Thuy N Vien; Michael A Ackley; James J Doherty; Paul A Davies; Stephen J Moss
Journal:  J Biol Chem       Date:  2019-06-25       Impact factor: 5.157

Review 2.  Novel Therapeutics in Glaucoma Management.

Authors:  Claudio Bucolo; Chiara Bianca Maria Platania; Filippo Drago; Vincenza Bonfiglio; Michele Reibaldi; Teresio Avitabile; Maurizio Uva
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

3.  LC-MS identification and preparative HPLC isolation of Frankenia pulverulenta phenolics with antioxidant and neuroprotective capacities in PC12 cell line.

Authors:  Rim Ben Mansour; Megdiche Ksouri Wided; Stéphanie Cluzet; Stéphanie Krisa; Tristan Richard; Riadh Ksouri
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 4.  Steroids and Alzheimer's Disease: Changes Associated with Pathology and Therapeutic Potential.

Authors:  Yvette Akwa
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

5.  Steroids and Brain, a Rising Bio-Medical Domain: a Perspective.

Authors:  Etienne-Emile Baulieu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-15       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.